STOCK TITAN

CordovaCann furnishes 2019–2026 reports to U.S. investors

(Neutral)
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

CordovaCann Corp. (LVRLF) is furnishing a package of historical Canadian disclosure documents to U.S. investors through this Form 6-K. The submission compiles interim financial statements with accompanying MD&A, news releases, material change reports, and a change-of-auditor package covering periods from October 2019 through March 31, 2026.

The exhibits include multiple sets of interim financial statements and MD&A for quarter- and year-end periods, numerous news releases and related material change reports, and a collection of documents relating to a change of auditor, all organized from the latest to the earliest disclosure date.

Positive

  • None.

Negative

  • None.
Interim Financial Statements financial
"Interim Financial Statements and MD&A for the period ended March 31, 2026"
Interim financial statements are condensed financial reports covering a short period within a fiscal year—commonly a quarter or month—showing a company’s revenue, expenses, cash flow and snapshot of assets and liabilities for that period. They matter to investors because they provide an up-to-date, mid-year scorecard of performance and trends between annual reports, helping spot improving or deteriorating prospects so decisions can be timed appropriately.
MD&A financial
"Interim Financial Statements and MD&A for the period ended March 31, 2026"
Management’s Discussion and Analysis (MD&A) is a section of a company’s financial filing where executives explain recent results, the reasons behind changes, risks faced, and expectations for the future in plain language alongside the numbers. Investors use it like an owner’s narrative to understand the story behind the raw financial data — what drove performance, potential pitfalls, and management’s plans — helping judge whether the company’s numbers are likely to improve or worsen.
Material Change Report regulatory
"Material Change Report (including News Release dated April 21, 2022)"
A material change report is a public notice that a company must file and share whenever new information or an event is significant enough to likely influence an investor’s decision. Think of it like an urgent update board that tells shareholders about big shifts—such as major deals, leadership changes, sudden losses, or legal issues—so investors can reassess risk and value with the same facts everyone else has.
change-of-auditor financial
"The change-of-auditor package includes the news release"
foreign private issuer regulatory
"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does CordovaCann Corp. (LVRLF) report in this Form 6-K?

CordovaCann Corp. furnishes a comprehensive set of historical Canadian disclosure documents, including interim financial statements, MD&A, news releases, material change reports, and a change-of-auditor package, covering the period from October 2019 through March 31, 2026.

Which financial periods for LVRLF are included in the furnished interim financial statements and MD&A?

The exhibits include interim financial statements and MD&A for multiple periods, including those ended March 31, 2026, December 31, 2025, September 30, 2025, and numerous earlier quarters and year-ends back to at least September 30, 2020 and earlier periods in 2021 and 2022.

Does this CordovaCann (LVRLF) Form 6-K include a change-of-auditor disclosure?

Yes. One exhibit is a change-of-auditor package, which includes a news release dated October 28, 2025, a notice of change of auditor dated October 13, 2025, a letter from the former auditor, and a letter from the successor auditor, all dated October 13, 2025.

What types of news releases for LVRLF are furnished in this Form 6-K?

The filing lists numerous news releases from 2019 through 2026, some accompanied by related material change reports. Examples include releases dated June 30, 2025, November 7, 2022, June 29, 2022, August 19, 2021, and multiple dates in 2020 and 2019.

Are the CordovaCann (LVRLF) documents in this Form 6-K updated or current?

The company states that each historical document furnished as an exhibit speaks only as of its original date and has not been updated, except where expressly indicated in the document itself or in the description of the exhibit.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of September 2026

 

Commission File Number: 000-50492

 

CORDOVACANN CORP.

(Translation of registrant’s name into English)

 

217 Queen Street West, Suite 401

Toronto, Ontario M5V 0R2, Canada

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

☒ Form 20-F      ☐ Form 40-F

 

 

 

 

EXPLANATORY NOTE

 

This Report on Form 6-K furnishes certain historical public disclosure materials previously made public in Canada. Each historical document furnished as an exhibit speaks only as of its original date and has not been updated, except as expressly indicated in that document or in the description of the exhibit.

 

Exhibits 99.1 through 99.43 are ordered from the latest public disclosure date to the earliest public disclosure date. Documents relating to the same disclosure event are kept together in one exhibit package. The change-of-auditor package includes the news release, notice of change of auditor, letter from the former auditor and letter from the successor auditor.

 

 
2

 

 

EXHIBITS - LATEST TO EARLIEST

 

Exhibit No.

 

Description

99.1

 

Interim Financial Statements and MD&A for the period ended March 31, 2026

99.2

 

Interim Financial Statements and MD&A for the period ended December 31, 2025

99.3

 

Interim Financial Statements and MD&A for the period ended September 30, 2025

99.4

 

News Release dated October 28, 2025; Notice of Change of Auditor dated October 13, 2025; Letter from Former Auditor dated October 13, 2025; and Letter from Successor Auditor dated October 13, 2025

99.5

 

News Release dated June 30, 2025

99.6

 

Interim Financial Statements and MD&A for the period ended March 31, 2025

99.7

 

Interim Financial Statements and MD&A for the period ended December 31, 2024

99.8

 

Interim Financial Statements and MD&A for the period ended September 30, 2024

99.9

 

Interim Financial Statements and MD&A for the period ended March 31, 2024

99.10

 

Interim Financial Statements and MD&A for the period ended December 31, 2023

99.11

 

Interim Financial Statements and MD&A for the period ended September 30, 2023

99.12

 

Interim Financial Statements and MD&A for the period ended March 31, 2023

99.13

 

Interim Financial Statements and MD&A for the period ended December 31, 2022

99.14

 

Interim Financial Statements and MD&A for the period ended September 30, 2022

99.15

 

News Release dated November 7, 2022

99.16

 

News Release dated June 29, 2022

99.17

 

Interim Financial Statements and MD&A for the period ended March 31, 2022

99.18

 

Material Change Report (including News Release dated April 21, 2022)

99.19

 

Interim Financial Statements and MD&A for the period ended December 31, 2021

99.20

 

Interim Financial Statements and MD&A for the period ended September 30, 2021

99.21

 

News Release dated November 2, 2021

 

 
3

 

 

EXHIBITS - LATEST TO EARLIEST (CONTINUED)

 

Exhibit No.

 

Description

99.22

 

News Release dated August 19, 2021 and related Material Change Report

99.23

 

News Release dated August 4, 2021

99.24

 

Interim Financial Statements and MD&A for the period ended March 31, 2021

99.25

 

News Release dated March 8, 2021

99.26

 

News Release dated March 1, 2021

99.27

 

News Release dated February 19, 2021 and related Material Change Report

99.28

 

Interim Financial Statements and MD&A for the period ended December 31, 2020

99.29

 

News Release dated January 12, 2021

99.30

 

Material Change Report (including News Release dated December 2, 2020)

99.31

 

Interim Financial Statements and Corrected MD&A for the period ended September 30, 2020

99.32

 

News Release dated November 23, 2020

99.33

 

News Release dated September 21, 2020

99.34

 

News Releases dated August 17 and August 20, 2020 and related Material Change Report

99.35

 

News Release dated July 24, 2020

99.36

 

News Release dated June 9, 2020

99.37

 

Archival Web Copy of News Release dated May 25, 2020 and related Material Change Report

99.38

 

News Release dated April 24, 2020 and related Material Change Report

99.39

 

News Release dated May 19, 2020

99.40

 

News Release dated April 9, 2020 and related Material Change Report

99.41

 

News Release dated November 7, 2019

99.42

 

News Release dated October 31, 2019

99.43

 

News Release dated October 28, 2019

 

 
4

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  CORDOVACANNCORP.
       
Date: September 21, 2026 By: /s/ Taz Turner

 

Name:

Taz Turner

 

 

Title:

Chief Executive Officer

 

 
5

 

Filing Exhibits & Attachments

43 documents

Keep reading